Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories research & Development Expense ($M) ($M)
Postgres DB financial_values + XBRL
Latest, FY2025
2,942
Period ended Dec 31, 2025
Change on a year earlier
+3.4%
2,844 in FY2024
History
19 years
Since FY2007
Sources
13
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Research & Development Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,942 | +3.4% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 2,844 | +3.8% | Form 10-K (filed 2025-02-21) ↗ |
| FY2023 | Dec 31, 2023 | 2,741 | -5.1% | Form 10-K (filed 2024-02-16) ↗ |
| FY2022 | Dec 31, 2022 | 2,888 | +5.3% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 2,742 | +13.3% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 2,420 | -0.8% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 2,440 | +6.1% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 2,300 | +1.8% | Form 10-K (filed 2019-02-22) ↗ |
| FY2017 | Dec 31, 2017 | 2,260 | +56.2% | Form 10-K (filed 2019-02-22) ↗ |
| FY2016 | Dec 31, 2016 | 1,447 | +3.0% | Form 10-K (filed 2019-02-22) ↗ |
| FY2015 | Dec 31, 2015 | 1,405 | +4.5% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 1,345 | -1.9% | Form 10-K (filed 2015-02-27) ↗ |
| FY2013 | Dec 31, 2013 | 1,371 | -6.2% | Form 10-K (filed 2015-02-27) ↗ |
| FY2012 | Dec 31, 2012 | 1,461 | -3.4% | Form 10-K (filed 2015-02-27) ↗ |
| FY2011 | Dec 31, 2011 | 1,512 | -59.4% | Form 10-K (filed 2014-02-21) ↗ |
| FY2010 | Dec 31, 2010 | 3,724 | +35.7% | Form 10-K (filed 2011-02-18) ↗ |
| FY2009 | Dec 31, 2009 | 2,744 | +2.0% | Form 10-K (filed 2010-02-19) ↗ |
| FY2008 | Dec 31, 2008 | 2,689 | +7.3% | Form 10-K (filed 2010-02-19) ↗ |
| FY2007 | Dec 31, 2007 | 2,506 | – | Form 10-K (filed 2010-02-19) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Research & Development Expense ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-is-rd
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.